TTRX (Turn Therapeutics Inc. Common Stock) Stock Analysis - SEC Filings
Turn Therapeutics Inc. Common Stock (TTRX) is a publicly traded the market company. As of May 21, 2026, TTRX trades at $4.48 with a market cap of $145.96M and a P/E ratio of -40.28. TTRX moved +0.00% today. Year to date, TTRX is +0.63%; over the trailing twelve months it is flat. Its 52-week range spans $2.57 to $26.50. Rallies surfaces TTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Where can I find TTRX SEC filings?
Rallies organizes TTRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.